As of 2025-12-16, the EV/EBITDA ratio of Biosynex SA (ALBIO.PA) is -15.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBIO.PA's latest enterprise value is 66.18 mil EUR. ALBIO.PA's TTM EBITDA according to its financial statements is -4.17 mil EUR. Dividing these 2 quantities gives us the above ALBIO.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 4.3x | 4.2x |
| Forward P/E multiples | 5.9x - 11.4x | 8.6x |
| Fair Price | (4.37) - (4.02) | (4.49) |
| Upside | -1015.8% - -942.2% | -1040.5% |
| Date | EV/EBITDA |
| 2025-12-12 | -15.88 |
| 2025-12-11 | -15.91 |
| 2025-12-10 | -16.00 |
| 2025-12-09 | -15.92 |
| 2025-12-08 | -15.95 |
| 2025-12-05 | -15.88 |
| 2025-12-04 | -15.90 |
| 2025-12-03 | -15.91 |
| 2025-12-02 | -15.94 |
| 2025-12-01 | -15.97 |
| 2025-11-28 | -16.04 |
| 2025-11-27 | -15.97 |
| 2025-11-26 | -15.99 |
| 2025-11-25 | -15.98 |
| 2025-11-24 | -16.03 |
| 2025-11-21 | -16.05 |
| 2025-11-20 | -16.08 |
| 2025-11-19 | -16.08 |
| 2025-11-18 | -16.12 |
| 2025-11-17 | -16.03 |
| 2025-11-14 | -16.08 |
| 2025-11-13 | -16.05 |
| 2025-11-12 | -16.09 |
| 2025-11-11 | -16.18 |
| 2025-11-10 | -16.22 |
| 2025-11-07 | -16.17 |
| 2025-11-06 | -16.03 |
| 2025-11-05 | -16.17 |
| 2025-11-04 | -16.35 |
| 2025-11-03 | -16.48 |
| 2025-10-31 | -16.58 |
| 2025-10-30 | -16.55 |
| 2025-10-29 | -16.60 |
| 2025-10-28 | -16.64 |
| 2025-10-27 | -16.63 |
| 2025-10-24 | -16.66 |
| 2025-10-23 | -16.78 |
| 2025-10-22 | -16.80 |
| 2025-10-21 | -16.80 |
| 2025-10-20 | -16.80 |
| 2025-10-17 | -16.80 |
| 2025-10-16 | -16.82 |
| 2025-10-15 | -16.83 |
| 2025-10-14 | -16.80 |
| 2025-10-13 | -16.77 |
| 2025-10-10 | -16.80 |
| 2025-10-09 | -16.77 |
| 2025-10-08 | -16.89 |
| 2025-10-07 | -16.89 |
| 2025-10-06 | -16.67 |